Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Geron Corp (NASDAQ: GERN) closed the day trading at $1.35 up 6.30% from the previous closing price of $1.27. In other words, the price has increased by $6.30 from its previous closing price. On the day, 15.6 million shares were traded. GERN stock price reached its highest trading level at $1.4286 during the session, while it also had its lowest trading level at $1.27.
Ratios:
For a better understanding of GERN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.12 and its Current Ratio is at 5.56. In the meantime, Its Debt-to-Equity ratio is 0.88 whereas as Long-Term Debt/Eq ratio is at 0.80.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, B. Riley Securities on February 27, 2025, Downgraded its rating to Neutral and sets its target price to $2 from $3.50 previously.
On November 05, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $8.H.C. Wainwright initiated its Buy rating on November 05, 2024, with a $8 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 27 ’25 when Samuels Scott Alan bought 15,000 shares for $1.61 per share. The transaction valued at 24,150 led to the insider holds 26,682 shares of the business.
SCARLETT JOHN A bought 12,500 shares of GERN for $22,062 on Feb 27 ’25. The Chairman, President and CEO now owns 12,500 shares after completing the transaction at $1.76 per share. On Feb 27 ’25, another insider, Ziegler James, who serves as the EVP, Chief Commercial Officer of the company, bought 100,000 shares for $1.60 each. As a result, the insider paid 160,000 and bolstered with 100,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GERN now has a Market Capitalization of 859832576 and an Enterprise Value of 574971008. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.17 while its Price-to-Book (P/B) ratio in mrq is 2.92. Its current Enterprise Value per Revenue stands at 7.468 whereas that against EBITDA is -3.32.
Stock Price History:
The Beta on a monthly basis for GERN is 0.81, which has changed by -0.6142857 over the last 52 weeks, in comparison to a change of 0.017286062 over the same period for the S&P500. Over the past 52 weeks, GERN has reached a high of $5.34, while it has fallen to a 52-week low of $1.17. The 50-Day Moving Average of the stock is -26.31%, while the 200-Day Moving Average is calculated to be -61.61%.
Shares Statistics:
Over the past 3-months, GERN traded about 15.36M shares per day on average, while over the past 10 days, GERN traded about 12922310 shares per day. A total of 606.39M shares are outstanding, with a floating share count of 597.84M. Insiders hold about 6.13% of the company’s shares, while institutions hold 76.62% stake in the company. Shares short for GERN as of 1743379200 were 59894969 with a Short Ratio of 3.90, compared to 1740700800 on 58414777. Therefore, it implies a Short% of Shares Outstanding of 59894969 and a Short% of Float of 9.83.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
